Abstract

BackgroundSystemic Immune-inflammation Index (SII) and body composition parameters are easily assessed, and can predict overall survival (OS) in various cancers, allowing early intervention. This study aimed to assess the correlation...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study
Qian-Tong Dong ... Dong-Dong Huang
Clinical nutrition (Edinburgh, Scotland) | VOL. 40
Qian-Tong Dong, et. al.Qian-Tong Dong ... Dong-Dong Huang
11 Nov 2020
Clinical impact of obesity-related factors in perioperative management of esophageal cancer.
Hiroya Takeuchi ... Hirofumi Kawakubo
Journal of Clinical Oncology | VOL. 36
Hiroya Takeuchi, et. al.Hiroya Takeuchi ... Hirofumi Kawakubo
01 Feb 2018
Impact of single and dual neoadjuvant HER2-directed therapy on clinical outcomes among patients with HER2-positive breast cancer (BC).
Kerry Lynn Reynolds ... Barbara Lynn Smith
Journal of Clinical Oncology | VOL. 31
Kerry Lynn Reynolds, et. al.Kerry Lynn Reynolds ... Barbara Lynn Smith
20 May 2013
Neoadjuvant single and dual HER2 blockade among patients with localized HER2-positive breast cancer.
Kerry Lynn Reynolds ... Michelle Connolly Specht
Journal of Clinical Oncology | VOL. 31
Kerry Lynn Reynolds, et. al.Kerry Lynn Reynolds ... Michelle Connolly Specht
10 Sep 2013
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
EphA3 CAR T cells are effective against glioblastoma in preclinical models
Paulo Martins ... Rajiv Khanna
Journal for Immunotherapy of Cancer | VOL. 12
Paulo Martins, et. al.Paulo Martins ... Rajiv Khanna
07 Aug 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses
Leesa Lertsumitkul ... Misty R Jenkins
Journal for Immunotherapy of Cancer | VOL. 12
Leesa Lertsumitkul, et. al.Leesa Lertsumitkul ... Misty R Jenkins
07 Aug 2024
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden
Michael Schenker ... Massimo Di Nicola
Journal for Immunotherapy of Cancer | VOL. 12
Michael Schenker, et. al.Michael Schenker ... Massimo Di Nicola
06 Aug 2024
Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer
Zixiang Wang ... Baoxia Cui
Journal for Immunotherapy of Cancer | VOL. 12
Zixiang Wang, et. al.Zixiang Wang ... Baoxia Cui
06 Aug 2024
View more papers